Cited by 295Antifungal resistance and susceptibilityNeutropenia and Cancer InfectionsFungal Infections and Studies

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

Predictors of Adverse Outcome in Cancer Patients with Candidemia

Anaissie, Elias J, Rex, John H, Uzun, Ömrün, Vartivarian, Shahe·1998·The American Journal of Medicine

Open this paper in CoChat — free account

Abstract

Background Many factors, including severity of illness, neutropenia, intravenous catheter management, and drug therapy may affect the outcome of candidemia in cancer patients.Methods The records of all patients at M. D. Anderson Cancer Center who developed one or more positive blood cultures for Candida spp between January 1, 1988, and December 31, 1992, were retrospectively reviewed. Four hundred ninety-one episodes of candidemia were identified, for which 476 had complete medical records, which were reviewed in detail.Results By 3-month follow-up, 52% of the patients had died. Neutropenia, higher APACHE III score, and visceral dissemination were associated with poor prognosis. Cure rates, adjusted for severity of illness, were similar for fluconazole and amphotericin B treatment. Exchange of central venous catheters was associated with a modest improvement in prognosis.Conclusion Several factors that influence the outcome of candidemia in cancer patients have been identified. These factors may be relevant for the clinical management of cancer patients with candidemia, and for the design of therapeutic trials.

Integrity signals

Registry

Crossref · 10.1016/s0002-9343(98)00030-8

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The APACHE III Prognostic System
Knaus, W. A., Wagner, D. P., Draper, E. A., Zimmerman, J. E., Bergner, M., BASTOS, P. G., Sirio, C., Murphy, D. J., Lotring, T., Damiano, A., et al. (1991) · CHEST Journal · doi:10.1378/chest.100.6.1619 · Cited by 3,539
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. A. (1992) · CHEST Journal · doi:10.1378/chest.102.6.1919b · Cited by 2,896
A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related Infection
Maki, D. G., Weise, C. E., & Sarafin, H. W. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706092962301 · Cited by 2,052
The Pathogenesis of Sepsis
Bone, R. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-457 · Cited by 1,357
Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality
Pittet, D. (1994) · JAMA · doi:10.1001/jama.271.20.1598 · Cited by 1,354
A simplified acute physiology score for ICU patients
Gall, J. L., Loirat, P., Alpérovitch, A., GLASER, P., Granthil, C., Mathieu, D., MERCIER, P., THOMAS, R., & Villers, D. (1984) · Critical Care Medicine · doi:10.1097/00003246-198411000-00012 · Cited by 1,247
A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Self-citation
Nosocomial Bloodstream Infection in Critically III Patients
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 946
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
Abi‐Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H., & Vartivarian, S. (1997) · Clinical Infectious Diseases · doi:10.1086/513663 · Cited by 755
Self-citation

Show all 36 references

Research works printed but not linked: 1

Phillips P, Shafran S, Garber G, et al. Fluconazole (FLU) versus amphotericin B (AMB) for candidemia in non-neutropenic patients: a multicenter randomized trial. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995, Abstract No. LM20.

Sorted by citations

Items 101–200 of 295

Treatment of Severe Candida Infections in High-Risk Patients in Germany: Consensus Formed by a Panel of Interdisciplinary Investigators
T., B., W., F., H., B., N., B., K.-H., D., M., H., D., H., U., J., G., J.-N., M., K., et al. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0730-4 · Cited by 53
Current strategies for the prevention and management of central line-associated bloodstream infections
Marschall, J. (2010) · Infection and Drug Resistance · doi:10.2147/idr.s10105 · Cited by 54
Report of ESGNI–001 and ESGNI–002 studies. Bloodstream infections in Europe
Bouza, E., Pérez-Molina, J. A., & Muñóz, P. (1999) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1999.tb00536.x · Cited by 53
Invasive candidiasis in cancer patients: observations from a randomized clinical trial
DiNubile, M. J., Hille, D. A., Sable, C. A., & Kartsonis, N. A. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.01.016 · Cited by 53
Infections Caused by Percutaneous Intravascular Devices
Beekmann, S. E., & Henderson, D. K. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00302-7 · Cited by 51
Surgical critical care: Fungal infections in surgical patients
Lipsett, P. A. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000231883.93001.e0 · Cited by 51
Epidemiological study of Candida infections in blood: susceptibilities of Candida spp. to antifungal agents, and clinical features associated with the candidemia
Nakamura, T., & Takahashi, H. (2006) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0438-y · Cited by 50
Central venous catheter (CVC) removal for patients of all ages with candidaemia
Janum, S., & Afshari, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011195.pub2 · Cited by 50
Management of intravascular catheter-related infections
RAAD, I. I. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.3.267 · Cited by 50
Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil
Bergamasco, M. D., Garnica, M., Colombo, A. L., & Nucci, M. (2012) · Mycoses · doi:10.1111/myc.12013 · Cited by 47
Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients
Hadley, S., Lee, W. W., Ruthazer, R., & Nasraway, S. A. (2002) · Critical Care Medicine · doi:10.1097/00003246-200208000-00023 · Cited by 46
Enhanced Killing ofCandida albicansby Human Macrophages Adherent to Type 1 Collagen Matrices via Induction of Phagolysosomal Fusion
Newman, S. L., Bhugra, B., Holly, A., & Morris, R. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.770-777.2005 · Cited by 46
The Ess1 Prolyl Isomerase Is Required for Growth and Morphogenetic Switching inCandida albicans
Devasahayam, G., Chaturvedi, V. P., & Hanes, S. D. (2002) · Genetics · doi:10.1093/genetics/160.1.37 · Cited by 46
Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida
Warn, P. A. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh153 · Cited by 46
The Challenge of Invasive Fungal Infection
Pauw, B. E. D., & Meunier, F. (1999) · Chemotherapy · doi:10.1159/000048465 · Cited by 45
Diagnosis and Management of Long-term Central Venous Catheter Infections
Hall, K. K., & Farr, B. M. (2004) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000121405.46920.87 · Cited by 45
Acute disseminated candidiasis with skin lesions: a systematic review
Guaraná, M., & Nucci, M. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.016 · Cited by 44
Recommendations for the management of candidemia in adults in Latin America
Nucci, M., Thompson-Moya, L., Guzmán-Blanco, M., Tiraboschi, I. N., Cortés, J. A., Echevarria, J. I., Sifuentes‐Osornio, J., Zurita, J., Santolaya, M. E., Matute, T. A., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.007 · Cited by 42
Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections
del Pozo, J. L., Alonso, M. M., Serrera, A., Hernáez, S., Aguinaga, A., & Leiva, J. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.10.004 · Cited by 41
Etiology and outcome of oral mucosal lesions in children on chemotherapy for acute lymphoblastic leukemia.
Anirudhan, D., Bakhshi, S., Xess, I., Broor, S., & Arya, L. S. (2008) · PubMed · Cited by 41
Multiple‐species candidemia in patients with cancer
Boktour, M. R., Kontoyiannis, D. P., Hanna, H. A., Hachem, R. Y., Girgawy, E., Bodey, G. P., & RAAD, I. I. (2004) · Cancer · doi:10.1002/cncr.20573 · Cited by 41
Predictors of outcome in cancer patients with candidemia
Uzun, Ö., & Anaissie, E. J. (2000) · Annals of Oncology · doi:10.1023/a:1008308923252 · Cited by 41
Self-citation
Effect of Neutropenia and Treatment Delay on the Response to Antifungal Agents in Experimental Disseminated Candidiasis
Hope, W. W., Drusano, G. L., Moore, C. B., Sharp, J., Louie, A., Walsh, T. J., Denning, D. W., & Warn, P. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00601-06 · Cited by 40
Prevention and Management of Long-Term Catheter Related Infections in Cancer Patients
Hachem, R. Y., & RAAD, I. I. (2002) · Cancer Investigation · doi:10.1081/cnv-120015984 · Cited by 40
The Role of Heparin and Glycocalyx in Blood–Brain Barrier Dysfunction
Yang, R., Chen, M., Zheng, J., Li, X., & Zhang, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.754141 · Cited by 42
Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection
Klevay, M. J., Horn, D. L., Neofytos, D., Pfaller, M. A., & Diekema, D. J. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.03.007 · Cited by 40
Design of Efficacy Trials of Cytokines in Combination with Antifungal Drugs
Kullberg, B. J., Lashof, A. M. L. O., & Netea, M. G. (2004) · Clinical Infectious Diseases · doi:10.1086/421960 · Cited by 39
Synergistic effect of amphotericin B and tyrosol on biofilm formed by Candida krusei and Candida tropicalis from intrauterine device users
Shanmughapriya, S., Sornakumari, H., Lency, A., Kavitha, S., & Natarajaseenivasan, K. (2014) · Medical Mycology · doi:10.1093/mmy/myu046 · Cited by 38
Frequency and antimicrobial susceptibility patterns of bacterial pathogens isolated from septicemic patients in Makkah hospitals
Asghar, A. H. (2006) · Saudi Medical Journal · doi:10.15537/1658-3175.3348 · Cited by 38
The predictors of outcome in immunocompetent patients with hematogenous candidasis
Safdar, A., Bannister, T., & Safdar, Z. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.05.003 · Cited by 38
The pathophysiology and treatment of Candida sepsis
Spellberg, B. J., & Edwards, J. E. (2002) · Current Infectious Disease Reports · doi:10.1007/s11908-002-0005-3 · Cited by 37
Persistent Candidemia: Causes and Investigations
Nucci, M. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0039-1 · Cited by 36
Cytokines in immunodeficient patients with invasive fungal infections: an emerging therapy
Roilides, E., Gil‐Lamaignere, C., & Farmaki, E. (2002) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(02)90104-9 · Cited by 37
Usefulness of guideline recommendations for prognosis in patients with candidemia
Cuervo, G., García‐Vidal, C., Puig‐Asensio, M., Merino, P., Vena, A., Martín‐Peña, A., Montejo, J. M., Gaitán, A. C. R., Lázaro-Perona, F., Fortün, J., et al. (2018) · Medical Mycology · doi:10.1093/mmy/myy118 · Cited by 36
Blood Stream Infections by Candida glabrata and Candida krusei: A Single-Center Experience
Choi, H. K., Jeong, S. J., Lee, H. S., Chin, B. S., Choi, S. H., Han, S. H., Kim, M. S., Kim, C. O., Choi, J. Y., Song, Y. G., et al. (2009) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2009.24.3.263 · Cited by 36
Considerations in the approach to invasive fungal infection in patients with haematological malignancies
Bow, E. J. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06906.x · Cited by 36
Fluconazole Disk Diffusion Test with Methylene Blue- and Glucose-Enriched Mueller-Hinton Agar for Determining Susceptibility of Candida Species
Lee, S.-C., Fung, C., Lee, N., See, L., Huang, J., Tsai, C.-J., Chen, K.-S., & Wb, S. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.4.1615-1617.2001 · Cited by 35
The Public Health and Probiotic Significance of Yeasts in Foods and Beverages
Fleet, G. H., & Balia, R. L. (2006) · Springer eBooks · doi:10.1007/978-3-540-28398-0_12 · Cited by 34
Recommendations for the management of candidemia in children in Latin America
Santolaya, M. E., Telles, F. D. Q., Matute, T. A., Colombo, A. L., Zurita, J., Tiraboschi, I. N., Cortés, J. A., Thompson-Moya, L., Guzmán-Blanco, M., Sifuentes‐Osornio, J., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.010 · Cited by 37
Candidemia in the 21st Century
Chang, A., Neofytos, D., & Horn, D. (2008) · Future Microbiology · doi:10.2217/17460913.3.4.463 · Cited by 35
Infection in Hematopoietic Stem Cell Transplantation
Boeckh, M., & Marr, K. A. (2002) · Springer eBooks · doi:10.1007/0-306-47527-8_16 · Cited by 34
Diagnose und Therapie von Pilzinfektionen und der Pneumozystis-Pneumonie bei Kindern und Jugendlichen mit neoplastischen Erkrankungen
Groll, A. H., & Ritter, J. (2005) · Klinische Pädiatrie · doi:10.1055/s-2005-872501 · Cited by 32
Clinical Manifestations and Molecular Epidemiology of Late Recurrent Candidemia, and Implications for Management
Clancy, C. J., Barchiesi, F., DiFrancesco, L., Morris, A. J., Snydman, D. R., Yu, V. L., Scalise, G., & Nguyen, M. H. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960000335 · Cited by 33
Safety and Efficacy of Multilamellar Liposomal Nystatin against Disseminated Candidiasis in Persistently Neutropenic Rabbits
Groll, A. H., Petraitis, V., Petraitienė, R., Field‐Ridley, A., Calendario, M., Bacher, J., Piscitelli, S. C., & Walsh, T. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2463 · Cited by 33
Time of catheter removal in candidemia and mortality
Nucci, M., Braga, P. R., Nouér, S. A., & Anaissie, E. J. (2018) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2018.10.278 · Cited by 32
Self-citation
Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.
Nace, H., Horn, D., & Neofytos, D. (2009) · Diagnostic microbiology and infectious disease · doi:10.1016/j.diagmicrobio.2009.03.010 · Cited by 35
Predictors of adverse outcome from candidal infection in a tertiary care hospital
Ben‐Abraham, R., Keller, N., Teodorovitch, N., Barzilai, A., Harel, R., Barzilay, Z., & Paret, G. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.02.015 · Cited by 32
The End of an Era in Defining the Optimal Treatment of Invasive Candidiasis
Clancy, C. J., & Nguyen, M. H. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis023 · Cited by 31
Treatment of opportunistic mycoses: how long is long enough?
Singh, N. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00802-8 · Cited by 32
Management of Invasive Candidiasis in the Intensive Care Unit
Playford, E. G., Lipman, J., & Sorrell, T. C. (2010) · Drugs · doi:10.2165/10898550-000000000-00000 · Cited by 29
Coping with Candida Infections
Evans, S. E. (2010) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200907-075al · Cited by 27
A Clinical Perspective for the Management of Invasive Fungal Infections: Focus on IDSA Guidelines
Kontoyiannis, D. P. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.12.175s.34506 · Cited by 29
In Vivo Inhibitory Effect on the Biofilm Formation of Candida albicans by Liverwort Derived Riccardin D
Li, Y., Ma, Y.-K., Zhang, L., Guo, F., Ren, L., Yang, R., Li, Y., & Lou, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035543 · Cited by 28
Candidemia in the in-patient setting: treatment options and economics
Gagne, J. J., & Goldfarb, N. I. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1643 · Cited by 27
Candida pseudorugosa sp. nov., a Novel Yeast Species from Sputum
Li, J., Xu, Y., & Bai, F. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01391-06 · Cited by 26
Central line infections
Lane, R. K., & Matthay, M. A. (2002) · Current Opinion in Critical Care · doi:10.1097/00075198-200210000-00012 · Cited by 26
1,2,3‐Triazole Derivatives as an Emerging Scaffold for Antifungal Drug Development against Candida albicans: A Comprehensive Review
Singh, A., Singh, K., Sharma, A., Joshi, K., Singh, B., Sharma, S., Batra, K., Kaur, K., Singh, D., Chadha, R., et al. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202300024 · Cited by 27
Complications infectieuses liées aux chambres implantables : caractéristiques et prise en charge
Lebeaux, D., Zarrouk, V., Leflon‐Guibout, V., Lefort, A., & Fantin, B. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2010.06.014 · Cited by 25
Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease
Cornely, O. A., Marty, F. M., Stucker, F., Pappas, P. G., & Ullmann, A. J. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02045.x · Cited by 24
Candidiasis
Vázquez, J. A., & Sobel, J. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_11 · Cited by 26
Thromboinflammation in Sepsis and Heparin: A Review of Literature and Pathophysiology
Vagionas, D., Papadakis, D., Politou, M., Koutsoukou, A., & Vasileiadis, I. (2022) · In Vivo · doi:10.21873/invivo.12991 · Cited by 23
Non-albicans Candida species isolated from plastic devices
Dorko, E., Kmeto'á, M., Marossy, A., Dorko, F., & Molokácová, M. (1999) · Mycopathologia · doi:10.1023/a:1007178806720 · Cited by 23
Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon γ on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages
Baltch, A. L., Bopp, L. H., Smith, R. P., Ritz, W. J., Carlyn, C. J., & Michelsen, P. B. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.02.017 · Cited by 23
Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
Lee, S.-C., Lo, H., Fung, C., Lee, N., & See, L. (2009) · PubMed · Cited by 22
Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium
Tiraboschi, I. N., Bennett, J. E., Kauffman, C. A., Rex, J. H., Girmenia, C., Sobel, J. D., & Menichetti, F. (2000) · Medical Mycology · doi:10.1080/mmy.38.s1.199.204 · Cited by 22
Self-citation
Candidemia Diagnosed from Peripheral Blood Smear: Case Report and Review of Literature 1954–2013
Hirai, Y., Asahata, S., Ainoda, Y., Fujita, T., Miura, H., Hizuka, N., & Kikuchi, K. (2015) · Mycopathologia · doi:10.1007/s11046-015-9884-3 · Cited by 21
Enfermedad fúngica invasora en pacientes hemato-oncológicos y receptores de trasplante de precursores hematopoyéticos bajo la perspectiva de los criterios diagnósticos EORTC/MSG
Ricardo Rabagliati, B., Gino Fuentes, L., Ana María Guzmán, D., Eric Orellana, U., Jorge Oporto, C., Igor Aedo, C., Marcelo Garrido, S., & Bruno Nervi, N. (2009) · Revista chilena de infectología · doi:10.4067/s0716-10182009000400002 · Cited by 21
Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients
Liu, F., Wu, T., Wang, J. B., Cao, X. Y., Yin, Y., Zhao, Y. L., & Lu, D. (2013) · Transplant Infectious Disease · doi:10.1111/tid.12068 · Cited by 21
Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis
González-Lara, M. F., Torres‐González, P., Cornejo‐Juárez, P., Velázquez-Acosta, C., Martínez‐Gamboa, A., Rangel‐Cordero, A., Bobadilla-del-Valle, M., Ostrosky-Zeichner, L. L., Ponce‐de‐León, A., & Sifuentes‐Osornio, J. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2846-2 · Cited by 23
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006)
Kumar, A., & Kethireddy, S. (2010) · Yearbook of Critical Care Medicine · doi:10.1016/s0734-3299(09)79335-9 · Cited by 21
Antifungal activity of splenic, liver and pulmonary macrophages against Candida albicans and effects of macrophage colony-stimulating factor
Lyman, C. A., Sein, T., Gonzalez, C., Walsh, T. J., & Roilides, E. (2000) · Medical Mycology · doi:10.1080/714030930 · Cited by 21
Emergence of resistant Candida in neutropenic patients
Nucci, M., & Colombo, A. L. (2002) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702002000300004 · Cited by 21
Candidemia Risk Prediction (CanDETEC) Model for Patients With Malignancy: Model Development and Validation in a Single-Center Retrospective Study
Yoo, J., Kim, S., Hur, S., Ha, J., Huh, K., & Cha, W. C. (2021) · JMIR Medical Informatics · doi:10.2196/24651 · Cited by 20
Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei and Candida parapsilosis in human monocyte-derived macrophages
Bopp, L. H., Baltch, A. L., Ritz, W. J., Michelsen, P. B., & Smith, R. P. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46393-0 · Cited by 20
Candida infections in children treated with conventional chemotherapy for solid tumors (transplant recipients excluded): The Institut Gustave Roussy Pediatrics Department experience
Ridola, V., Chachaty, É., Raimondo, G., Corradini, N., Brugières, L., Valteau‐Couanet, D., & Hartmann, O. (2003) · Pediatric Blood & Cancer · doi:10.1002/pbc.10452 · Cited by 20
Etiología de episodios de neutropenia febril en pacientes adultos con cáncer hematológico y de órganos sólidos en el Hospital Clínico Universidad Católica, Santiago-Chile
Ricardo Rabagliati, B., Gino Fuentes, L., Eric Orellana, U., Jorge Oporto, C., Isabel Domínguez, M., Rosana Benítez, G., Igor Aedo, C., Germán Ramos, G., Marcelo Garrido, S., & Patricia García, C. (2009) · Revista chilena de infectología · doi:10.4067/s0716-10182009000200001 · Cited by 19
Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis
Miyazaki, T., & Kohno, S. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1058157 · Cited by 18
Clinical impacts of delayed central venous catheter removal according to the severity of comorbidities in patients with candidaemia
Lee, Y., Kim, D. Y., Kim, Y. J., Park, K., & Lee, M. S. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.08.018 · Cited by 18
Candida
Dignani, M. C., Solomkin, J. S., & Anaissie, E. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00008-6 · Cited by 19
Self-citation
Invasive Candida infections in the ICU
Eggimann, P., Barberini, L., Calandra, T., & Marchetti, O. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02151.x · Cited by 17
Candidemia y candidiasis invasora en el adulto. Formas clínicas y tratamiento
Cervera, C. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2012.02.003 · Cited by 35
Outcome of totally implantable venous access device-related bacteraemia without device removal
Cherifi, S., Jacobs, F., Strale, H., Struelens, M. J., & Byl, B. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01699.x · Cited by 17
Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia
Yu, D., Seger, D. L., Peterson, J. F., Kumar, R. N., & Bates, D. W. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-173 · Cited by 16
Tratamiento de las infecciones fúngicas en pacientes con neoplasias hematológicas
Mensa, J., de la Cámara, R., Carreras, E., Estrella, M. C., Rodríguez, J. Á. G., Gobernado, M., Picazo, J., Aguado, J. M., & Sanz, M. Á. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2009.01.008 · Cited by 16
Invasive fungal infections in cancer patients
Anaissie, E. J., Grazziutti, M., & Nucci, M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00020-7 · Cited by 17
Self-citation
Emerging issues in nosocomial fungal infections
Toscano, C. M., & Jarvis, W. R. (1999) · Current Infectious Disease Reports · doi:10.1007/s11908-999-0041-3 · Cited by 16
A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999
Lortholary, O. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh348 · Cited by 16
High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study
Torres, H. A., Kontoyiannis, D. P., & Rolston, K. V. I. (2004) · Supportive Care in Cancer · doi:10.1007/s00520-004-0601-x · Cited by 16
Guías de práctica clínica para el manejo de la candidiasis: actualización del 2009, de la Infectious Diseases Society of America
Pappas, P. G., Kauffman, C. A., Andes, D. R., Benjamin, D. K., Calandra, T., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B. J., Ostrosky-Zeichner, L. L., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598961 · Cited by 16
Self-citation
Infections in Patients with Hematologic Malignancies
Papanicolaou, G. A., & Mehta, J. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-644-3_3 · Cited by 15
The epidemiology and management of candidemia in Northern Ireland during 2002−2011, including a 12-month enhanced case review
Spiers, R., Smyth, B., Lamagni, T. L., Rooney, P. J., Dorgan, E., Wyatt, T. D., Geoghegan, L., & Patterson, L. (2017) · Medical Mycology · doi:10.1093/mmy/myx165 · Cited by 15
Mixed fungaemia: an 18-year report from a tertiary-care university hospital and a systematic review
Gülmez, D., Alp, Ş., Gürsoy, G., Ayaz, Ç. M., Doğan, Ö., Arıkan-Akdağlı, S., & Akova, M. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.03.030 · Cited by 15
Candidaemia in cancer patients and in children in a neonatal intensive care unit
Trubenová, D., Viragova, S., Pilipcinec, E., Danko, J., Švický, E., & Tkáčiková, Ľ. (2001) · Folia Microbiologica · doi:10.1007/bf02873597 · Cited by 15
Response of Symptomatic Persistent Chronic Disseminated Candidiasis to Corticosteroid Therapy in Immunosuppressed Pediatric Patients: Case Study and Review of the Literature
Shkalim‐Zemer, V., Levi, I., Fischer, S., Tamary, H., Yakobovich, J., Avrahami, G., Gilad, G., Elitzur, S., Yaniv, I., Elhasid, R., et al. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001844 · Cited by 14
Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed?
Eggimann, P., Wolff, M., & Garbino, J. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2806-y · Cited by 14
Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer
Millar, M. R., Zhou, W., Skinner, R., Pizer, B. L., Hennessy, E., Wilks, M., & Gilbert, R. E. (2011) · Health Technology Assessment · doi:10.3310/hta15070 · Cited by 13
INVASIVE CANDIDA INFECTIONS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES AND HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: CURRENT EPIDEMIOLOGY AND THERAPEUTIC OPTIONS.
Girmenia, C., Finolezzi, E., & Federico, V. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.013 · Cited by 14
Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia
Chandrasekar, P. H., Sirohi, B., Seibel, N. L., Hsu, J. W., Azie, N. E., Wu, C., & Ruhnke, M. (2018) · Mycoses · doi:10.1111/myc.12748 · Cited by 13
Invasive fungal infection in children undergoing chemotherapy for cancer
Yeh, T., Liu, H., Wang, L.-Y., Chen, S., & Liang, D. (2007) · Annals of Tropical Paediatrics · doi:10.1179/146532807x192516 · Cited by 13
Novel strategies for treating candidiasis
Polonelli, L., & Cassone, A. (1999) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-199902000-00011 · Cited by 13

Authors: Anaissie, E. J., Rex, J. H., Uzun, Ö., & Vartivarian, S.
Affiliations: The University of Texas MD Anderson Cancer Center (US)
The University of Texas Health Science Center at Houston (US)
Corresponding author: Anaissie, Elias J
ORCID: Rex, John H
Venue: The American Journal of Medicine
Publisher: Elsevier BV
Published: 1998-03
Volume: 104
Issue: 3
Pages: 238-245
ISSN: 0002-9343 (ISSN-L)
DOI: 10.1016/s0002-9343(98)00030-8
OpenAlex: W2083121860
Cited by: 295
References: 36
Citations by year: 2026: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 1 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 1 · 2015: 9 · 2014: 6 · 2013: 9 · 2012: 11
FWCI: 11.04
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The American Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: Pfizer Pharmaceuticals
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords: candidemia, candidiasis, cancer patients, prognosis, neutropenia, APACHE III score, visceral dissemination, fluconazole, amphotericin B, mortality, bloodstream infection
MeSH terms: Adult, Aged, Analysis of Variance, Antifungal Agents, Candidiasis, Female, Humans, Male, Middle Aged, Neoplasms, Predictive Value of Tests, Prognosis, Retrospective Studies, Risk, Risk Factors, Time Factors, Odds Ratio, Fungemia, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Predictors of Adverse Outcome in Cancer Patients with Candidemia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks